Gw Pharma ADR (GWPH)
$106.62 0.92 (0.87%)
17:25 EST GWPH Stock Quote Delayed 15 Minutes
Previous Close -
Market Cap 3.01B
PE Ratio -
Volume (Avg. Vol.) 594,600
Day's Range 105.85 - 109.05
52-Week Range 90.14 - 196.00
Dividend & Yield N/A (N/A)
GWPH Stock Predictions, Articles, and Gw Pharma ADR News
- From InvestorPlace
- From the Web
Uber, Match Group, Kirkland Lake Gold, Humana and GW Pharma were our top stock trades from Wednesday. Let's look at the charts.
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
GW stock has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked cannabis stock.
These stocks to buy base at least some of their revenue on CBD and are poised to buck the downtrend that has hit the larger cannabis stocks.
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
Admittedly, GWPH stock could go either way before earnings. The sector in general has suffered amid falling prices for dried cannabis. With valuations still elevated, GWPH may need to offer a “perfect” report to keep the stock price from falling.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
Despite May's large losses, these stocks to buy made new 52-week highs. Maybe this is a signal that they will continue to head higher.
The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.
This week started strong for GW Pharmaceuticals, as management continues to deliver on promises, so GWPH stock should continue to deliver profits.
GW Pharmaceuticals (GWPH) reported its latest quarterly earnings results after hours today, bringing in sales that surged more than 1200%.
Medical cannabis’ cheap costs and natural uses will benefit GW Pharmaceuticals stock in the long run, keeping GWPH stock growing.
The ETFMG Alternative Harvest (MJ) ETF enables investors to take advantage of long-term trends in marijuana stocks.
GW Pharmaceutical reported its quarterly earnings results late on Tuesday, bringing in revenue that was thrice the amount it was a year ago.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
Tuesday’s Midday Movers: Bluebird Bio (BLUE), Clovis Oncology (CLVS), Sangamo Biosciences (SGMO), GW Pharma (GWPH)
From Analyst Ratings
So far Tuesday, December 10, NASDAQ is up 0.45% and the S&P is up 0.14%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Bluebird Bio (BLUE – Research Report), Clovis Oncology (CLVS – Research Report), Sangamo Biosciences (SGMO – Research Report) and GW Pharma (GWPH – Research Report).
Navellier RatingsPowered by Portfolio Grader